Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Neoadjuvant chemotherapy (NAC) can downstage axillary nodes in breast cancer, prompting debate over the optimal axillary management after NAC. While axillary dissection (ALND) provides detailed assessment of node status, minimally invasive methods such as sentinel lymph node biopsy (SLNB), marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) are showing promise. This meta-analysis aims to assess the efficacy and safety of these strategies.

Methods: A systematic search of Medline, Embase and Cochrane Central was conducted and relevant RCTs were identified. Random-effects meta-analysis, meta-regression and trial sequential analysis (TSA) were conducted for diagnostic outcomes (identification rates [IFR], false negative rates [FNR] and negative predictive value [NPV]) and survival outcomes (overall survival [OS], disease-free survival [DFS]) to compare SLNB, MLNB and TAD with ALND.

Results: Twenty-eight studies (SLNB, n = 3392; MLNB, n = 1130; TAD, n = 946) investigated diagnostic outcomes and nine studies investigated survival outcomes (n = 5647). The pooled IFR, FNR and NPV of TAD was 96.8 %, 4.7 % and 93.2 %, respectively, and all values were superior to SLNB (91.9 %, 13.7 % and 84.8 %; meta-regression, p < 0.001) (SLNB vs. MLNB concordance = 73 %). The FNR of SLNB decreased with the number of nodes removed (≥3 nodes, 8.1 %) but remained inferior to TAD (p = 0.001). The IFR of SLNB in the ycN0 group was statistically lower than all patients (ycN0/+), 85.8 % vs. 91.9 % (p < 0.001). Pooled hazard ratios for DFS in SLNB/TAD, SLNB and TAD were 0.90 (95%CI, 0.77-1.04; p = 0.45), 0.89 (95%CI, 0.74-1.08; p = 0.25) and 0.91 (95%CI, 0.64-1.29; p = 0.58) (TSA 2.08>threshold). Indirect comparison between TAD and SLNB demonstrated no significant difference in DFS (HR 0.98; 0.64-1.32; 95%CI, p = 0.95).

Conclusion: Targeted axillary dissection is the optimal minimally invasive axillary technique in terms of diagnostic accuracy. De-escalation of axillary surgery following NAC does not negatively impact DFS in patients with node-positive breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2025.109689DOI Listing

Publication Analysis

Top Keywords

minimally invasive
8
breast cancer
8
neoadjuvant chemotherapy
8
meta-regression trial
8
trial sequential
8
sequential analysis
8
axillary dissection
8
lymph node
8
node biopsy
8
diagnostic outcomes
8

Similar Publications

Fibrin Sealant-Assisted Fixation of an Autologous Iliac Bone Graft in Orbital Floor Reconstruction.

J Craniofac Surg

September 2025

Division of Ophthalmic Plastic and Reconstructive Surgery, Sadik Eratik Eye Institute, Haydarpasa Numune Education and Research Hospital, University of Health Sciences.

Orbital floor fractures can lead to enophthalmos and diplopia, often requiring surgical intervention to restore orbital volume. Autologous iliac bone grafts are commonly used due to their biocompatibility and mechanical stability, but achieving adequate fixation remains a challenge. Traditional fixation methods, such as plates and screws, may introduce risks of foreign body reactions, graft displacement, and surgical morbidity.

View Article and Find Full Text PDF

Difficult Single-Lead Spinal Cord Stimulator Trial for Failed Back Surgery Syndrome Salvages Treatment.

Pain Med Case Rep

December 2023

Beth Israel Deaconess Medical Center, Department of Anesthesiology, Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA.

Background: Spinal cord stimulation (SCS) is a minimally invasive neuromodulation treatment modality primarily used for failed back surgery syndrome (FBSS), complex regional pain syndrome, and diabetic neuropathy. Specifically, when utilized for the treatment of FBSS, placement can be complicated by the excessive scarring, adhesions, and altered anatomy limiting the access to the epidural space and advancement of the leads.

Case Report: Our patient is a 58-year-old woman with a history of scoliosis and severe lumbar spinal stenosis who presented for trial of an SCS for FBSS.

View Article and Find Full Text PDF

Background: Spinal cord stimulation (SCS) is a minimally invasive neuromodulation treatment modality primarily indicated for failed back surgery syndrome (FBSS). When FBSS occurs in the setting of spinal cord injury (SCI) it can often be refractory to treatment with opioids and anticonvulsants; in such cases, SCS has demonstrated promising results. Here, we present a case series of 2 patients with FBSS in the setting of SCI who received pain relief with SCS therapy.

View Article and Find Full Text PDF

Background: Platelet-rich plasma (PRP) therapy has shown promising results in promoting healing and reducing inflammation in musculoskeletal injuries. This case report highlights the successful use of PRP injection therapy in a 37-year-old woman pedestrian with a sacral fracture and coccydynia from a pedestrian-vehicle accident.

Case Report: The patient underwent traversing sacral S3 anterior cortex vertebral fracture and sacrococcygeal PRP injection under fluoroscopic guidance.

View Article and Find Full Text PDF

Topic: The aim of this study was to assess the meta-analysis of the studies comparing transepithelial photorefractive keratectomy (TransPRK) to classical photorefractive keratectomy (PRK) (mechanical or alcohol-assisted).

Clinical Relevance: While PRK is a well-established procedure, TransPRK, a newer, minimally invasive technique may reduce surgery time and improve patient outcomes. Comparing these techniques helps optimize surgical choices.

View Article and Find Full Text PDF